IVACAFTOR\TEZACAFTOR: 5,420 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
5,420
Total FAERS Reports
95 (1.8%)
Deaths Reported
3,026
Hospitalizations
5,420
As Primary/Secondary Suspect
19
Life-Threatening
8
Disabilities
First Report: 2017 · Latest Report: 20250901
What Are the Most Common IVACAFTOR\TEZACAFTOR Side Effects?
#1 Most Reported
Infective pulmonary exacerbation of cystic fibrosis
1,211 reports (22.3%)
#2 Most Reported
Hospitalisation
593 reports (10.9%)
#3 Most Reported
Infection
333 reports (6.1%)
All IVACAFTOR\TEZACAFTOR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Infective pulmonary exacerbation of cystic fibrosis | 1,211 | 22.3% | 4 | 1,002 |
| Hospitalisation | 593 | 10.9% | 11 | 588 |
| Infection | 333 | 6.1% | 1 | 186 |
| Pneumonia | 247 | 4.6% | 2 | 207 |
| Headache | 214 | 4.0% | 1 | 20 |
| Cystic fibrosis | 194 | 3.6% | 4 | 176 |
| Cough | 178 | 3.3% | 0 | 60 |
| Cystic fibrosis respiratory infection suppression | 153 | 2.8% | 0 | 151 |
| Pulmonary function test decreased | 153 | 2.8% | 2 | 108 |
| Haemoptysis | 139 | 2.6% | 0 | 91 |
| Nausea | 138 | 2.6% | 0 | 26 |
| Dyspnoea | 137 | 2.5% | 2 | 63 |
| Malaise | 128 | 2.4% | 0 | 57 |
| Nasopharyngitis | 100 | 1.9% | 1 | 22 |
| Fatigue | 96 | 1.8% | 0 | 24 |
| Influenza | 85 | 1.6% | 0 | 45 |
| Dizziness | 83 | 1.5% | 0 | 17 |
| Abdominal pain upper | 82 | 1.5% | 1 | 18 |
| Weight decreased | 81 | 1.5% | 2 | 48 |
| Sinusitis | 73 | 1.4% | 0 | 15 |
Who Reports IVACAFTOR\TEZACAFTOR Side Effects? Age & Gender Data
Gender: 57.3% female, 42.7% male. Average age: 26.2 years. Most reports from: US. View detailed demographics →
Is IVACAFTOR\TEZACAFTOR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 10 | 0 | 4 |
| 2018 | 1,343 | 16 | 643 |
| 2019 | 2,434 | 39 | 1,610 |
| 2020 | 486 | 17 | 303 |
| 2021 | 63 | 2 | 49 |
| 2022 | 22 | 1 | 13 |
| 2023 | 24 | 0 | 16 |
| 2024 | 18 | 0 | 13 |
| 2025 | 10 | 0 | 8 |
What Is IVACAFTOR\TEZACAFTOR Used For?
| Indication | Reports |
|---|---|
| Cystic fibrosis | 5,227 |
| Product used for unknown indication | 14 |
| Bacterial disease carrier | 9 |
IVACAFTOR\TEZACAFTOR vs Alternatives: Which Is Safer?
IVACAFTOR\TEZACAFTOR vs IVERMECTIN
IVACAFTOR\TEZACAFTOR vs IVOSIDENIB
IVACAFTOR\TEZACAFTOR vs IXABEPILONE
IVACAFTOR\TEZACAFTOR vs IXAZOMIB
IVACAFTOR\TEZACAFTOR vs IXEKIZUMAB
IVACAFTOR\TEZACAFTOR vs JAKAFI
IVACAFTOR\TEZACAFTOR vs JANUMET
IVACAFTOR\TEZACAFTOR vs JANUVIA
IVACAFTOR\TEZACAFTOR vs JETREA
IVACAFTOR\TEZACAFTOR vs JUXTAPID
Official FDA Label for IVACAFTOR\TEZACAFTOR
Official prescribing information from the FDA-approved drug label.